FDA Adverse Event Injury Summary report: N

ACCU-CHEK ® RAPID-D INFUSION SET

MDR report key: 3123556 · Received May 22, 2013

Report

Report Number
2183996-2013-00905
Event Type
Injury
Date Received
May 22, 2013
Date of Event
November 4, 2012
Report Date
June 11, 2013
Manufacturer
FRESENIUS KABI DEUTSCHLAND GMBH
Product Code
FPA
PMA / PMN Number
K003977
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

IT WAS UNKNOWN IF THE INITIAL REPORTER SENT REPORT TO THE FDA. NO PRODUCT AVAILABLE TO BE RETURNED.

Additional Manufacturer Narrative · 1

NO PRODUCT WAS RETURNED FOR EVALUATION. LOT/SERIAL NUMBER IS NOT AVAILABLE. THEREFORE NO INVESTIGATION WAS POSSIBLE. NO PRODUCT WAS RETURNED.

Description of Event or Problem · 1

ON (B)(6) 2013, IT WAS REPORTED THAT THE PATIENT HAD INSERTED HER INFUSION SITE AND IMMEDIATELY FELT A STINGING SENSATION. SHE REMOVED THE INFUSION SET AND CHOSE A DIFFERENT INFUSION SITE. HOWEVER, THE STINGING DID NOT GO AWAY FROM THE PREVIOUS SITE OVER THE COURSE OF THE FOLLOWING DAYS. THE SITE BECAME RED AND BRUISED. AFTER A WEEK, THE PATIENT STATED BROWN FLUID WAS COMING FROM THE SITE AND SHE WENT TO SEE HER DOCTOR. ON (B)(6) 2012, HER DOCTOR TOLD HER THAT THE SITE WAS INFECTED AND SHE NEEDED TO GO TO THE HOSPITAL. SHE WENT TO THE HOSPITAL AND SHE WAS GIVEN EMERGENCY SURGERY. SHE WAS IN THE HOSPITAL FOR THREE DAYS. THE PATIENT STATED THAT SHE HAS BEEN AFRAID TO USE HER INFUSION DEVICE SINCE THE INCIDENT. THE PATIENT WAS SENT COMPLIMENTARY INFUSION SETS SO SHE CAN RESUME USE OF THE INFUSION DEVICE. THE PATIENT DISCARDED THE USED INFUSION SET. NO PRODUCT WILL BE REQUESTED TO BE RETURNED FOR PRODUCT EVALUATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
225841 ACCU-CHEK ® RAPID-D INFUSION SET SUBCUTANEOUS INFUSION SET FPA FRESENIUS KABI DEUTSCHLAND GMBH NA ASKU

Patients

Seq Age Sex Outcome Treatment
1 045 YR Hospitalization| R SOMA| NORCO| APIDRA INSULIN